CTA
Chesley Taft & Associates Portfolio holdings
AUM
$2.24B
This Quarter Return
+6.42%
1 Year Return
+19.18%
3 Year Return
+75.84%
5 Year Return
+120.98%
10 Year Return
+286.6%
AUM
$1.18B
AUM Growth
+$1.18B
(+2%)
Cap. Flow
-$32.2M
Cap. Flow
% of AUM
-2.73%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
290
New
12
Increased
88
Reduced
126
Closed
5
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$6.2M |
| 2 |
Apple
AAPL
|
$6.17M |
| 3 |
RTN
Raytheon Company
RTN
|
$2.11M |
| 4 |
Amgen
AMGN
|
$2.02M |
| 5 |
PayPal
PYPL
|
$1.28M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$18M |
| 2 |
Merck
MRK
|
$4.52M |
| 3 |
Exxon Mobil
XOM
|
$4.12M |
| 4 |
Accenture
ACN
|
$3.12M |
| 5 |
Microsoft
MSFT
|
$2.97M |
Sector Composition
| 1 | Technology | 14.85% |
| 2 | Healthcare | 14.6% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Staples | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
DuPont de Nemours
DD
$31.6B
| $7.36M | 0.62% |
103,296
-14,097
| -12% | -$1M |
|
52
Northern Trust
NTRS
$24.7B
| $7.32M | 0.62% |
73,266
+50
| +0.1% | +$5K |
|
53
Bristol-Myers Squibb
BMY
$96.7B
| $7.24M | 0.61% |
118,075
+4,425
| +4% | +$271K |
|
54
Salesforce
CRM
$245B
| $7.22M | 0.61% |
70,574
-1,052
| -1% | -$108K |
|
55
GE Aerospace
GE
$293B
| $7.07M | 0.6% |
405,102
-90,310
| -18% | -$1.58M |
|
56
Cognizant
CTSH
$35.1B
| $6.92M | 0.59% |
97,430
-274
| -0.3% | -$19.5K |
|
57
Church & Dwight Co
CHD
$22.7B
| $6.86M | 0.58% |
136,700
-46,597
| -25% | -$2.34M |
|
58
Intercontinental Exchange
ICE
$100B
| $6.78M | 0.57% |
96,101
-280
| -0.3% | -$19.8K |
|
59
Union Pacific
UNP
$132B
| $6.75M | 0.57% |
50,305
+725
| +1% | +$97.2K |
|
60
IBM
IBM
$227B
| $6.42M | 0.54% |
41,827
+701
| +2% | +$108K |
|
61
UnitedHealth
UNH
$279B
| $6.25M | 0.53% |
28,359
-175
| -0.6% | -$38.6K |
|
62
Starbucks
SBUX
$99.2B
| $6.02M | 0.51% |
104,781
-5,065
| -5% | -$291K |
|
63
Weyerhaeuser
WY
$17.9B
| $6.01M | 0.51% |
170,382
+321
| +0.2% | +$11.3K |
|
64
Blackrock
BLK
$170B
| $5.77M | 0.49% |
11,238
-90
| -0.8% | -$46.2K |
|
|
ESRX
65
DELISTED
Express Scripts Holding Company
ESRX
| $5.57M | 0.47% |
74,615
-2,774
| -4% | -$207K |
|
66
iShares National Muni Bond ETF
MUB
$38.6B
| $5.24M | 0.44% |
47,350
-2,825
| -6% | -$313K |
|
67
Novartis
NVS
$248B
| $5.24M | 0.44% |
62,402
-86
| -0.1% | -$7.22K |
|
68
NXP Semiconductors
NXPI
$57.5B
| $5.15M | 0.44% |
44,009
-1,430
| -3% | -$167K |
|
69
Fiserv
FI
$74.3B
| $5.1M | 0.43% |
38,915
-5,125
| -12% | -$672K |
|
70
McDonald's
MCD
$226B
| $5.08M | 0.43% |
29,487
-5,064
| -15% | -$872K |
|
71
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $5.02M | 0.43% |
48,038
-38
| -0.1% | -$3.97K |
|
72
Willis Towers Watson
WTW
$31.9B
| $4.92M | 0.42% |
32,627
+38
| +0.1% | +$5.73K |
|
73
Procter & Gamble
PG
$370B
| $4.68M | 0.4% |
50,951
+58
| +0.1% | +$5.33K |
|
|
74
Merck
MRK
$210B
| $4.56M | 0.39% |
81,056
-80,346
| -50% | -$4.52M |
|
75
iShares Biotechnology ETF
IBB
$5.68B
| $4.35M | 0.37% |
40,776
+26,968
| +195% | -$69.2K |
|